Deciphering the genetics factors underlying age-related neurodegenerative diseases in the Alzheimer’s-Parkinson’s spectrum has
Deciphering the genetics factors underlying age-related neurodegenerative diseases in the Alzheimer’s-Parkinson’s spectrum has a translational potential to advance the development of highly informative and precise biomarkers. Genetic biomarkers can facilitate clinical setting in several aspects, such as, enrichment of drug trials with individuals at high risk, tools for obtaining an early diagnosis, and mechanistic insights for drug development. Collectively, decoding the genetic architecture of these complex neurological diseases will provide the foundation for precision medicine in AD and PD in the future.
Dr. Ornit Chiba-Falek is a researcher in Duke’s Department of Neurobiology.
Videos & Readings:
- Towards precision medicine in Alzheimer’s disease: deciphering genetic data to establish informative biomarkers – US National Library of Medicine, NIH
- Targeted genome editing as “next generation drugs” for Parkinson’s disease – Duke Neurology
Where to meet:
Selected attendees will be notified via email several days in advance of the dinner with details regarding meeting location. All dinners will be within reasonable driving distance to Duke campus.
Science & Society will also provide a shuttle for those unable to arrange transportation to the dinner dialogue location. Shuttles will depart 30 minutes before the scheduled event from the front entrance of the North Building on West Campus. Click here for a map.
(Wednesday) 7:00 pm - 8:30 pm
Comments are closed.